The Latest Breaking News on Pharma

Here are some of the key moments from the last two days, as the South African President’s visit to the UK continues.

Biotech company Bionano Genomics (BNGO) has beaten analysts’ top-line estimate in the third quarter. However, its cash and cash equivalents balance has declined year-over-year. Therefore, is it a buy now under $3? Read on to find out….

Among the more remarkable legacies of the COVID-19 pandemic is how quickly federal regulators, the health care industry and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

BHUBANESWAR: The Odisha government on Wednesday launched Anaemia Mukta Lakhya Abhiyan (Amlan), a multi-departmental campaign to reduce anaemia or haemoglobin deficiency in the state.

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.